Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 119

    1.

    Idd loci synergize to prolong islet allograft survival induced by costimulation blockade in NOD mice.

    Mangada J, Pearson T, Brehm MA, Wicker LS, Peterson LB, Shultz LD, Serreze DV, Rossini AA, Greiner DL.

    Diabetes. 2009 Jan;58(1):165-73. Epub 2008 Nov 4.PMID: 18984741 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Islet allograft survival induced by costimulation blockade in NOD mice is controlled by allelic variants of Idd3.

    Pearson T, Weiser P, Markees TG, Serreze DV, Wicker LS, Peterson LB, Cumisky AM, Shultz LD, Mordes JP, Rossini AA, Greiner DL.

    Diabetes. 2004 Aug;53(8):1972-8.PMID: 15277375 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Genetic disassociation of autoimmunity and resistance to costimulation blockade-induced transplantation tolerance in nonobese diabetic mice.

    Pearson T, Markees TG, Serreze DV, Pierce MA, Marron MP, Wicker LS, Peterson LB, Shultz LD, Mordes JP, Rossini AA, Greiner DL.

    J Immunol. 2003 Jul 1;171(1):185-95.PMID: 12816997 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.
    5.

    Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.

    Molano RD, Berney T, Li H, Cattan P, Pileggi A, Vizzardelli C, Kenyon NS, Ricordi C, Burkly LC, Inverardi L.

    Diabetes. 2001 Feb;50(2):270-6.PMID: 11272136 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.

    Nanji SA, Hancock WW, Luo B, Schur CD, Pawlick RL, Zhu LF, Anderson CC, Shapiro AM.

    Diabetes. 2006 Jan;55(1):27-33.PMID: 16380473 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    NOD congenic mice genetically protected from autoimmune diabetes remain resistant to transplantation tolerance induction.

    Pearson T, Markees TG, Wicker LS, Serreze DV, Peterson LB, Mordes JP, Rossini AA, Greiner DL.

    Diabetes. 2003 Feb;52(2):321-6.PMID: 12540603 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms.

    Banuelos SJ, Markees TG, Phillips NE, Appel MC, Cuthbert A, Leif J, Mordes JP, Shultz LD, Rossini AA, Greiner DL.

    Transplantation. 2004 Sep 15;78(5):660-7.PMID: 15371665 [PubMed - indexed for MEDLINE]Related articles

    9.

    Autoimmune diabetes and resistance to xenograft transplantation tolerance in NOD mice.

    Gordon EJ, Wicker LS, Peterson LB, Serreze DV, Markees TG, Shultz LD, Rossini AA, Greiner DL, Mordes JP.

    Diabetes. 2005 Jan;54(1):107-15.PMID: 15616017 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts.

    Thornley TB, Brehm MA, Markees TG, Shultz LD, Mordes JP, Welsh RM, Rossini AA, Greiner DL.

    J Immunol. 2006 Feb 1;176(3):1561-70.PMID: 16424185 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    NOD mice have a generalized defect in their response to transplantation tolerance induction.

    Markees TG, Serreze DV, Phillips NE, Sorli CH, Gordon EJ, Shultz LD, Noelle RJ, Woda BA, Greiner DL, Mordes JP, Rossini AA.

    Diabetes. 1999 May;48(5):967-74.PMID: 10331399 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade.

    Makhlouf L, Kishimoto K, Smith RN, Abdi R, Koulmanda M, Winn HJ, Auchincloss H Jr, Sayegh MH.

    Diabetes. 2002 Nov;51(11):3202-10.PMID: 12401711 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.

    Berney T, Pileggi A, Molano RD, Poggioli R, Zahr E, Ricordi C, Inverardi L.

    Transplantation. 2003 Dec 27;76(12):1669-74.PMID: 14688513 [PubMed - indexed for MEDLINE]Related articles

    14.

    Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.

    Drage M, Zaccone P, Phillips JM, Nicoletti F, Dawson J, Andrew Bradley J, Cooke A.

    Transplantation. 2002 Sep 15;74(5):611-9.PMID: 12352875 [PubMed - indexed for MEDLINE]Related articles

    15.

    The use of idd congenic mice to identify checkpoints of peripheral tolerance to islet antigen.

    Hamilton-Williams EE, Martinez X, Lyman M, Hunter K, Wicker LS, Sherman LA.

    Ann N Y Acad Sci. 2007 Apr;1103:118-27. Epub 2007 Mar 21.PMID: 17376833 [PubMed - indexed for MEDLINE]Related articles

    16.

    Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.

    Molano RD, Pileggi A, Berney T, Poggioli R, Zahr E, Oliver R, Malek TR, Ricordi C, Inverardi L.

    Transplantation. 2003 Jun 15;75(11):1812-9.PMID: 12811239 [PubMed - indexed for MEDLINE]Related articles

    17.

    Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.

    Ansari MJ, Fiorina P, Dada S, Guleria I, Ueno T, Yuan X, Trikudanathan S, Smith RN, Freeman G, Sayegh MH.

    Clin Immunol. 2008 Feb;126(2):140-7. Epub 2007 Sep 24.PMID: 17889619 [PubMed - indexed for MEDLINE]Related articles

    18.

    Natural killer T cell facilitated engraftment of rat skin but not islet xenografts in mice.

    Gordon EJ, Kelkar V.

    Xenotransplantation. 2009 May;16(3):135-44.PMID: 19566653 [PubMed - indexed for MEDLINE]Related articles

    19.

    Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.

    Sgouroudis E, Albanese A, Piccirillo CA.

    J Immunol. 2008 Nov 1;181(9):6283-92.PMID: 18941219 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.

    Shi Q, Wang D, Hadley GA, Farber DL, Bartlett ST.

    Surgery. 2006 Aug;140(2):281-8.PMID: 16904981 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data